TFG-003
Asset
- Stage
- Preclinical
- Modality
- Cell therapy
- Target
- Not known
- 0
- Indications
- 0
- Trials
- 1
- Developer
Indications
1No named disease
Preclinical, treefrog.fr, 10 Oct 2026
In the full profile
- Owner and partners1
Every asset’s record: target, stage, trials and the evidence behind it.